NewsRx

Search our medical news database

AIDS Weekly and Law

Susan Hasty, Publisher

Table of Contents . . . October 28th, 2004

Non-Subscriber - Summaries Only

Related Areas: Other Issues in AIDS Weekly and Law | Other Publications

Trinity Biotech plc - Biotech receives U.S. FDA approval for HIV test with finger stick whole blood

HIV/AIDS Treatment - Man claims doctor refused to perform surgery because of HIV

Inst Natl Sante Recherche Med E0109, Paris - CD8+ T cells specific for EBV/CMV/FLU activated during primary HIV infection

Starpharma - Australian company to lead NIH-funded project to prevent HIV, other STDs

U.S. National Institutes of Health - CD25+/CD4+ cells associated with favorable clinical markers of HIV status

AIDS Healthcare Foundation - California governor Schwarzenegger signs HIV/AIDS pharmacy bill

Chinese Academy of Science - Novel anti-HIV drug candidate targets CD4 lymphocytes

FEI - ParaGard offers safe, effective alternative to hormonal birth control

HIV/AIDS Prevention - Barcelona to play World XI in AIDS benefit

HIV/AIDS Prevention - England's Prime Minister and musician work to help Africa

HIV/AIDS Threat - Former President De Klerk says AIDS remains South Africa's biggest threat

HIV/AIDS Treatment - Committee approves needle exchange, treatment funding

Indiana University - Inhibitor design wraps packing defects in HIV-1 proteins

Inst. National Communicable Diseases, Johannesburg - JC virus genotypes 3 and 7 identified in South African patients

Institute Oswaldo Cruz, Rio De Janeiro - Furamidine analog markedly potentiates activity against T. cruzi/L. amazonensis

Johns Hopkins University - Some AIDS drugs promote neurological damage

Kurume University School of Medicine, Fukuoka - LAMPS of M. fermentans/M. penetrans activate HIV LTR through Toll-like receptors

Loma Linda University - HIV cholera toxin fusion gene expressed in transgenic potato

Mary Ann Liebert, Inc. - New book on medication adherence for AIDS patients offers solutions

Merck Research Laboratories - Novel HIV-1 integrase inhibitor has potent antiviral activity

National Jewish Medical Center, Denver - d4T treatment enhances mitochondrial oxidative stress

Slotervaart Hospital, Amsterdam - Race is not associated with pharmacokinetics of nevirapine

The Immune Response Corporation - Drug boosts HIV-1-specific lymphocyte activity in infected patients, study shows

U.S. National Institutes of Health - Pathogenic SHIVs and SIVs target different CD4+ T cell subsets

Univ. Mediterranee, Marseille - HIV-1 and MLV Gag sufficient to recruit APOBEC3G into virus-like particles

University Autonoma of Barcelona, Bellaterra - HIV-1 gp120 decreases NO-dependent cyclic GMP accumulation in brain astroglia

University College, London - New HIV technologies alter the nature of HIV medicine materially and socially

University of Alabama - Mutations alter capsid protein assembly rate without changing monomer stability

University of California San Francisco - Immune activation set point is established early in HIV infection

University of Minnesota - APOBEC3F properties/hypermutation preferences indicate activity against HIV-1

University of Rochester - HIV phenotypic/genotypic markers of resistance evaluated at virologic failure

University of Washington - Drug-resistant HIV mutants higher in PBMC than plasma after changes in ART

VA Medical Center, Houston - Fibronectin fragments stimulate transendothelial migration of HIV-1-infected MNL

Wildlife Trust - Hurricanes and extreme weather causing plant diseases

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook